About
ABOUT IBG
MISSION-VISION
STRATEGIC OBJECTIVES
BOARD OF DIRECTORS
DIRECTOR
ORGANIZATION CHART
ANNUAL REPORTS
COOPERATION MOVIE
Research
VACCINE DEVELOPMENT GROUP
BIOPHARMACEUTICAL PRODUCT DEVELOPMENT GROUP
BIOMEDICAL DEVICE AND TECHNOLOGY DEVELOPMENT GROUP
CELL THERAPY DRUG DEVELOPMENT GROUP
RARE AND UNDIAGNOSED DISEASES GROUP
OMICS AND COMPUTATIONAL BIOLOGY GROUP
TRANSLATIONAL RESEARCH GROUP
IBG-NEVCELL
DRUG ANALYSIS AND CONTROL LAB.
ETHICS BOARDS
AWARDS
SCIENTIFIC PUBLICATIONS
Research Support
RESEARCH SUPPORT UNITS
Optical Imaging
Flow Cytometry and Cell Sorting
Electron Microscopy
Histopathology
General Device Operating
Vivaryum
PRICE LIST
TECHNOLOGY PLATFORMS
IBG-Biobank Platform
IBG-PHARMA Platform
IBG-NEVCELL
Drug Analysis and Control Lab.
RESERVATION SYSTEM
Training
CONFERENCES AND COURSES
SEMINARS
POSTDOCTORAL TRAINING
AFFILIATED GRADUATE PROGRAMMES
INTERNSHIP
Jobs
News
NEWS FROM IBG
IBG IN THE MEDIA
ANNOUNCEMENTS
Press
Contact
IBG DIRECTORY
CONTACT
Intranet
STS
Türkçe (tr)
English (en)
Home
Training
Seminars
Targeting the Corrupted Epigenomes and Their Crosstalk with DNA Damage Response for Leukemia Treatment
Targeting the Corrupted Epigenomes and Their Crosstalk with DNA Damage Response for Leukemia Treatment
Aug. 15, 2025
